,
your personalized virtual assistant to find clinical trials. Go head, 
Stephanie Gregory, MD
Rush University Medical CenterChicago, Illinois - 60612 |
- CLINICAL TRIALS 6
- CONDITIONS9
- INTERVENTIONS9
- SINCE2006
A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell CLL Following Second Line Therapy (THE CONTINUUM TRIAL)
January 2009 - June 2018
Study of Pralatrexate to Treat Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
September 2009 - June 2013
Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma
October 2006 - October 2016
Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy
July 2009 - May 2016
Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell Lymphoma
November 2007 - November 2010
Safety and Efficacy of RAD001 in Patients With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade Therapy.
August 2008 - March 2011
Lymphoma
Lymphoma, Non-Hodgkin
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphoid
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
Lymphoma, Mantle-Cell
Burkitt Lymphoma
Placebo
Bevacizumab
Lenalidomide
Rad001
Pralatrexate Injection
Vitamin B12
Folic Acid
Regimen B
Regimen A
